HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tomoo Matsutani Selected Research

Diabetes Mellitus

4/2024JMJD6 Autoantibodies as a Potential Biomarker for Inflammation-Related Diseases.
10/2023Serum anti-PCK1 antibody levels are a prognostic factor for patients with diabetes mellitus.
1/2021Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as predictive risk markers for acute ischemic stroke.
12/2020Serum anti-LRPAP1 is a common biomarker for digestive organ cancers and atherosclerotic diseases.
10/2020Association between serum anti‑ASXL2 antibody levels and acute ischemic stroke, acute myocardial infarction, diabetes mellitus, chronic kidney disease and digestive organ cancer, and their possible association with atherosclerosis and hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tomoo Matsutani Research Topics

Disease

27Neoplasms (Cancer)
04/2024 - 01/2008
10Glioblastoma (Glioblastoma Multiforme)
05/2021 - 06/2009
9Atherosclerosis
04/2024 - 10/2020
9Glioma (Gliomas)
01/2020 - 01/2008
8Ischemic Stroke
04/2024 - 12/2020
6Transient Ischemic Attack
10/2023 - 01/2018
5Diabetes Mellitus
04/2024 - 10/2020
5Oligodendroglioma
09/2023 - 05/2011
5Cerebral Infarction
01/2023 - 06/2014
4Astrocytoma (Pilocytic Astrocytoma)
01/2020 - 03/2009
3Esophageal Squamous Cell Carcinoma
04/2024 - 10/2020
3Chronic Renal Insufficiency
01/2023 - 10/2020
3Colorectal Neoplasms (Colorectal Cancer)
01/2023 - 10/2020
3Brain Neoplasms (Brain Tumor)
12/2022 - 04/2016
2Myocardial Infarction
04/2024 - 01/2021
2Cardiovascular Diseases (Cardiovascular Disease)
04/2024 - 10/2023
2Inflammation (Inflammations)
04/2024 - 11/2021
2Carcinoma (Carcinomatosis)
04/2024 - 06/2009
2Residual Neoplasm
09/2015 - 05/2011
2Hepatocellular Carcinoma (Hepatoma)
06/2012 - 06/2009
1Stomach Neoplasms (Stomach Cancer)
04/2024
1Lung Neoplasms (Lung Cancer)
04/2024
1Unstable Angina
04/2024
1Stroke (Strokes)
04/2024
1Breast Neoplasms (Breast Cancer)
04/2024
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
04/2024
1Esophageal Neoplasms (Esophageal Cancer)
04/2024
1Obstructive Sleep Apnea
10/2023
1Autoimmune Diseases (Autoimmune Disease)
10/2023
1Neurologic Manifestations (Neurological Manifestations)
09/2023
1Kidney Diseases (Kidney Disease)
01/2023
1Infarction (Infarctions)
11/2021
1Neuroepithelial Neoplasms (Gliomatosis Cerebri)
07/2021
1Acute Coronary Syndrome
08/2020
1Multiple Myeloma
10/2015
1Disease Progression
10/2015
1Meningioma (Meningiomas)
06/2014
1Carcinogenesis
06/2014
1Lymphoma (Lymphomas)
04/2014
1Leukemia
03/2013

Drug/Important Bio-Agent (IBA)

12AntigensIBA
04/2024 - 10/2012
10AntibodiesIBA
04/2024 - 01/2018
9Proteins (Proteins, Gene)FDA Link
04/2024 - 06/2012
8Biomarkers (Surrogate Marker)IBA
04/2024 - 01/2008
8Complementary DNA (cDNA)IBA
04/2024 - 10/2012
7AutoantibodiesIBA
04/2024 - 10/2012
6Immunoglobulin G (IgG)IBA
04/2024 - 10/2020
4Temozolomide (Temodar)FDA LinkGeneric
09/2023 - 01/2010
4Phosphotransferases (Kinase)IBA
10/2015 - 06/2012
3ImmunosorbentsIBA
11/2021 - 10/2020
3Peptides (Polypeptides)IBA
01/2021 - 10/2012
3Mechanistic Target of Rapamycin Complex 2IBA
10/2015 - 10/2013
2NimustineIBA
09/2023 - 12/2011
2Vincristine (Oncovin)FDA LinkGeneric
09/2023 - 12/2011
2Procarbazine (Matulane)FDA Link
09/2023 - 12/2011
2Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
01/2020 - 01/2017
2DNA (Deoxyribonucleic Acid)IBA
01/2017 - 10/2013
2Mechanistic Target of Rapamycin Complex 1IBA
10/2015 - 10/2013
2TOR Serine-Threonine KinasesIBA
10/2015 - 03/2013
2MTOR InhibitorsIBA
10/2015 - 06/2012
2amsonic acid (DAS)IBA
09/2015 - 06/2011
2Adenosine Triphosphate (ATP)IBA
10/2013 - 09/2011
1C-Reactive ProteinIBA
04/2024
1PhosphoenolpyruvateIBA
10/2023
1Lomustine (CCNU)FDA Link
09/2023
1CytokinesIBA
01/2023
1Thiosulfate Sulfurtransferase (Rhodanese)IBA
01/2023
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2023
1Amino AcidsFDA Link
12/2022
1Cyclic AMP (AMP, Cyclic)IBA
01/2022
1DesminIBA
01/2022
1Transcription Factors (Transcription Factor)IBA
01/2022
1VimentinIBA
01/2022
1Immunologic Factors (Immunomodulators)IBA
11/2021
1LipidsIBA
07/2021
1SynaptophysinIBA
07/2021
1GlycolipidsIBA
05/2021
1LigandsIBA
05/2021
1Tretinoin (Retinoic Acid)FDA LinkGeneric
05/2021
1Methionine (L-Methionine)FDA Link
01/2021
1Adaptor Protein Complex 3IBA
01/2021
1Recombinant ProteinsIBA
01/2021
1Alkaline PhosphataseIBA
01/2017
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2016
1CC-223IBA
10/2015
1isocitric acid (isocitrate)IBA
09/2015
1FilaminsIBA
06/2014
1Methotrexate (Mexate)FDA LinkGeneric
04/2014
1epidermal growth factor receptor VIIIIBA
10/2013
16- (4- (1H- 1,2,4- triazol- 3- yl)phenyl)- 1- (2- (tetrahydro- 2H- pyran- 4- yl)ethyl)- 1H- imidazo(4,5- b)pyrazin- 2(3H)- oneIBA
10/2013
1CC214-2IBA
10/2013
1Sirolimus (Rapamycin)FDA Link
10/2013

Therapy/Procedure

6Radiotherapy
01/2021 - 03/2009
6Therapeutics
01/2020 - 12/2011
5Drug Therapy (Chemotherapy)
01/2019 - 01/2010
3Craniotomy
09/2023 - 09/2018
2Chemoradiotherapy
09/2023 - 01/2020
1Immunotherapy
05/2021
1Renal Dialysis (Hemodialysis)
01/2020
1Precision Medicine
01/2019